News for Wanbury Limited (WANBURY.BO)

Wanbury Limited approves financial decisions, raises ₹175 crore through NCDs, grants stock options, and reports Q3 results.

Shares of Wanbury locked in 5 per cent upper circuit on the BSE in Thursday's intraday trade

Wanbury Share Price: Shares of pharma company Wanbury climbed nearly 4 per cent on Friday after the company received an EIR with zero form 483 observations, from the USFDA

Wanbury Share Price: At 9:55 AM, the shares were off highs, trading 2.25 per cent higher at Rs 163.95 per share. In comparison, BSE Sensex was trading 0.16 per cent lower at 77,211.40 levels.

Q4 results today: Among the key companies reporting today, Biocon will be under scrutiny for its revenue growth and profit margins. Hindustan Aeronautics, a major player in the aerospace sector, will also post its results.

Wanbury Limited announced that at its EGM held on 18 November 2023 have approved the appointment of Mr. Pravin Dilip Pawar as the non-executive independent director of the company for a term of one...

Net Sales at Rs 144.46 crore in September 2023 up 16.54% from Rs. 123.96 crore in September 2022. Quarterly Net Profit at Rs. 7.36 crore in September 2023 up 9...

While indices soared, 62 stocks on the BSE touched fresh 52-week highs while 28 scrips on the exchange were down with losses, reaching fresh 52-week lows.